Valuation: BioElectronics Corporation

Market Cap 12.35M 10.79M 9.96M 9.18M 17.31M 1.19B 17.69M 119M 46.83M 583M 46.39M 45.37M 2.01B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.45M 20.72M 19.1M 36M 2.47B 36.8M 248M 97.41M 1.21B 96.49M 94.38M 4.17B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week-25.00%
1 month-25.00%
3 months-25.00%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 85 15/06/2020
Director/Board Member - 15/11/2019
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-25.00%+50.00%-40.00% 6.18M
-1.97%+1.03%+28.39%+1.68% 198B
-0.58%+2.40%+7.25%-15.35% 144B
-14.15%-15.08%-33.40%-2.68% 122B
-1.32%-1.65%-57.52%-16.63% 65.44B
-2.40%-7.03%+12.08%-6.81% 49.36B
-0.11%+1.53%-23.83%-30.51% 44.75B
-3.41%-2.11%+15.33%+9.95% 37.13B
-2.44%-1.98%+28.33%+35.71% 36.23B
-1.86%-2.39%-22.85%-10.01% 28.7B
Average -2.82%-4.94%+0.38%-7.46% 72.61B
Weighted average by Cap. -3.69%-1.84%-0.99%-4.99%

Financials

2020 2021
Net sales 830K 725K 669K 617K 1.16M 79.89M 1.19M 8M 3.14M 39.13M 3.12M 3.05M 135M 1.61M 1.41M 1.3M 1.2M 2.25M 155M 2.3M 15.51M 6.1M 75.91M 6.04M 5.91M 261M
Net income -1.16M -1.01M -935K -862K -1.62M -112M -1.66M -11.18M -4.4M -54.7M -4.36M -4.26M -188M -290K -253K -234K -215K -406K -27.91M -415K -2.79M -1.1M -13.67M -1.09M -1.06M -47.06M
Net Debt 13.07M 11.42M 10.54M 9.71M 18.31M 1.26B 18.71M 126M 49.54M 616M 49.08M 48M 2.12B 13.34M 11.66M 10.76M 9.92M 18.69M 1.28B 19.11M 129M 50.58M 629M 50.1M 49.01M 2.17B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
17/07/26 USD 0.000250 0.00% 3,050,150
16/07/26 USD 0.000250 -16.67% 10,915,644
15/07/26 USD 0.000300 0.00% 12,925,100
14/07/26 USD 0.000300 -14.29% 16,232,194
13/07/26 USD 0.000350 0.00% 609,150
  1. Stock Market
  2. Stocks
  3. BIEL Stock